Should You Invest in Neurocrine Biosciences, Inc. (NBIX) Now?
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has a higher price-to-earnings ratio of 59.64x compared to its average ratio, The 36-month beta value for NBIX is at
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has a higher price-to-earnings ratio of 59.64x compared to its average ratio, The 36-month beta value for NBIX is at
Neurocrine Biosciences, Inc. (NASDAQ: NBIX)’s stock price has plunge by 2.95relation to previous closing price of 137.74. Nevertheless, the company has seen a 7.22% surge
The price-to-earnings ratio for Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is 55.69x, which is above its average ratio. Moreover, the 36-month beta value for NBIX is
The stock of Neurocrine Biosciences, Inc. (NBIX) has seen a -2.23% decrease in the past week, with a -8.21% drop in the past month, and
The stock price of Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has surged by 133.84 when compared to previous closing price of 149.26, but the company has
In the past week, NBIX stock has gone down by -0.51%, with a monthly gain of 3.82% and a quarterly surge of 21.97%. The volatility
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.